Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Revenue TTM
0
25M
50M
75M
Q3 '16: 1.9M
Q4 '16: 1.9M
Q1 '17: 2.2M
Q2 '17: 2.4M
Q3 '17: 2.7M
Q4 '17: 3.7M
Q1 '18: 3.7M
Q2 '18: 3.3M
Q3 '18: 2.8M
Q4 '18: 1.7M
Q1 '19: 2.1M
Q2 '19: 2.6M
Q3 '19: 4.5M
Q4 '19: 6.7M
Q1 '20: 7.9M
Q2 '20: 9.4M
Q3 '20: 12.2M
Q4 '20: 15.8M
Q1 '21: 16M
Q2 '21: 16.1M
Q3 '21: 15M
Q4 '21: 12.9M
Q1 '22: 14M
Q2 '22: 17.3M
Q3 '22: 18.7M
Q4 '22: 19.6M
Q1 '23: 17.6M
Q2 '23: 24.5M
Q3 '23: 34.6M
Q4 '23: 44.5M
Q1 '24: 55.5M
Q2 '24: 55.9M
Q3 '24: 54.7M
Q4 '24: 56.7M
Q1 '25: 58.4M
Q2 '25: 60.8M
Q3 '25: 60.6M
Q4 '25: 59.2M
Q1 '26: 59M
Q2 '26: 57.2M
Q3 '17
Q4 '18
Q1 '20
Q2 '21
Q3 '22
Q4 '23
Q1 '25
Q2 '26
Gross Profit TTM
0
6M
12M
18M
Q3 '14: 269.8K
Q4 '14: 348.2K
Q1 '15: 416.7K
Q2 '15: 444.9K
Q3 '15: 512.5K
Q4 '15: 543.7K
Q1 '16: 575.6K
Q2 '16: 697.7K
Q3 '16: 715.4K
Q4 '16: 799.9K
Q1 '17: 931.1K
Q2 '17: 1M
Q3 '17: 1.2M
Q4 '18: 357.3K
Q1 '19: 384.7K
Q2 '19: 437.4K
Q3 '19: 1M
Q4 '20: 7.9M
Q1 '21: 8.5M
Q2 '21: 8.3M
Q3 '21: 7.6M
Q4 '21: 6.6M
Q1 '22: 7.3M
Q2 '22: 9.2M
Q3 '22: 9.2M
Q4 '22: 9.1M
Q1 '23: 7.9M
Q2 '23: 9.3M
Q3 '23: 10.5M
Q4 '23: 13.5M
Q1 '24: 16.1M
Q2 '24: 15.4M
Q3 '24: 16.4M
Q4 '24: 16.5M
Q1 '25: 17.6M
Q2 '25: 17.2M
Q3 '25: 17.1M
Q4 '25: 15.8M
Q1 '26: 15.8M
Q2 '26: 15.2M
Q3 '15
Q4 '16
Q1 '19
Q2 '21
Q3 '22
Q4 '23
Q1 '25
Q2 '26
Operating Income TTM
-75M
-50M
-25M
0
25M
50M
75M
Q3 '16: -2.2M
Q4 '16: -2.3M
Q1 '17: -2.3M
Q2 '17: -2.5M
Q3 '17: -2.5M
Q4 '17: -2.2M
Q1 '18: -2.2M
Q2 '18: -2.4M
Q3 '18: -2.7M
Q4 '18: -3.1M
Q1 '19: -3.2M
Q2 '19: -2.9M
Q3 '19: -4.2M
Q4 '19: -8.5M
Q1 '20: -10.9M
Q2 '20: -14.7M
Q3 '20: -16M
Q4 '20: -72.9M
Q1 '21: -73M
Q2 '21: -72.4M
Q3 '21: -71.6M
Q4 '21: -11.9M
Q1 '22: -10.8M
Q2 '22: -7.6M
Q3 '22: -6.3M
Q4 '22: -5.1M
Q1 '23: -5.8M
Q2 '23: -9.1M
Q3 '23: -25M
Q4 '23: -26.8M
Q1 '24: -26M
Q2 '24: -24M
Q3 '24: -7M
Q4 '24: -4.9M
Q1 '25: -3.1M
Q2 '25: -2.2M
Q3 '25: -2M
Q4 '25: -1.4M
Q1 '26: 563K
Q2 '26: 1.5M
Q3 '17
Q4 '18
Q1 '20
Q2 '21
Q3 '22
Q4 '23
Q1 '25
Q2 '26
Net Income TTM
-75M
-50M
-25M
0
25M
50M
75M
Q3 '16: -2.6M
Q4 '16: -2.7M
Q1 '17: -2.7M
Q2 '17: -3M
Q3 '17: -2.8M
Q4 '17: -3M
Q1 '18: -3.3M
Q2 '18: -3.3M
Q3 '18: -3.6M
Q4 '18: -5.2M
Q1 '19: -5M
Q2 '19: -4.8M
Q3 '19: -5.9M
Q4 '19: -4.2M
Q1 '20: -6.5M
Q2 '20: -9.9M
Q3 '20: -70.1M
Q4 '20: -72.7M
Q1 '21: -71.4M
Q2 '21: -71.8M
Q3 '21: -12.4M
Q4 '21: -12M
Q1 '22: -12.4M
Q2 '22: -9.4M
Q3 '22: -8.7M
Q4 '22: -8.1M
Q1 '23: -9.8M
Q2 '23: -14.4M
Q3 '23: -32M
Q4 '23: -35.6M
Q1 '24: -36.5M
Q2 '24: -35.7M
Q3 '24: -19.2M
Q4 '24: -17M
Q1 '25: -15.5M
Q2 '25: -14.4M
Q3 '25: -13.9M
Q4 '25: -13.5M
Q1 '26: -11.5M
Q2 '26: -10.6M
Q3 '17
Q4 '18
Q1 '20
Q2 '21
Q3 '22
Q4 '23
Q1 '25
Q2 '26
Cost of Revenue TTM
0
15M
30M
45M
Q4 '18: 1.4M
Q1 '19: 1.8M
Q2 '19: 2.1M
Q3 '19: 3.4M
Q4 '19: 5.8M
Q1 '20: 6.7M
Q2 '20: 7.3M
Q3 '20: 7.9M
Q4 '20: 7.9M
Q1 '21: 7.5M
Q2 '21: 7.8M
Q3 '21: 7.5M
Q4 '21: 6.3M
Q1 '22: 6.7M
Q2 '22: 8.1M
Q3 '22: 9.5M
Q4 '22: 10.5M
Q1 '23: 9.7M
Q2 '23: 15.2M
Q3 '23: 24.1M
Q4 '23: 31M
Q1 '24: 39.4M
Q2 '24: 40.5M
Q3 '24: 38.4M
Q4 '24: 40.2M
Q1 '25: 40.8M
Q2 '25: 43.6M
Q3 '25: 43.5M
Q4 '25: 43.4M
Q1 '26: 43.2M
Q2 '26: 42M
Q2 '19
Q2 '20
Q2 '21
Q2 '22
Q2 '23
Q2 '24
Q2 '25
Q2 '26
Operating Cash Flow TTM
-7.5M
-5M
-2.5M
0
2.5M
5M
7.5M
Q3 '16: -1.8M
Q4 '16: -1.9M
Q1 '17: -1.8M
Q2 '17: -1.9M
Q3 '17: -1.8M
Q4 '17: -1.7M
Q1 '18: -2M
Q2 '18: -2.2M
Q3 '18: -3.6M
Q4 '18: -4M
Q1 '19: -3.9M
Q2 '19: -3.6M
Q3 '19: -2.2M
Q4 '19: -2.8M
Q1 '20: -3.5M
Q2 '20: -4.6M
Q3 '20: -6.2M
Q4 '20: -6.5M
Q1 '21: -5.4M
Q2 '21: -5.7M
Q3 '21: -6.3M
Q4 '21: -5.9M
Q1 '22: -7.1M
Q2 '22: -6.7M
Q3 '22: -4.4M
Q4 '22: -3.1M
Q1 '23: -2.8M
Q2 '23: -3.9M
Q3 '23: -5.8M
Q4 '23: -4.7M
Q1 '24: -2.7M
Q2 '24: -1.4M
Q3 '24: 774K
Q4 '24: 1.9M
Q1 '25: 608K
Q2 '25: 3.5M
Q3 '25: 2.7M
Q4 '25: 1.3M
Q1 '26: 1.4M
Q2 '26: -465K
Q3 '17
Q4 '18
Q1 '20
Q2 '21
Q3 '22
Q4 '23
Q1 '25
Q2 '26
Free Cash Flow TTM
-7.5M
-5M
-2.5M
0
2.5M
5M
7.5M
Q2 '15: -1.6M
Q3 '15: -1.6M
Q4 '15: -1.6M
Q1 '16: -1.7M
Q2 '16: -1.7M
Q3 '16: -1.8M
Q4 '16: -1.9M
Q1 '17: -1.9M
Q2 '17: -2M
Q3 '17: -1.9M
Q4 '17: -1.7M
Q1 '18: -2M
Q2 '18: -2.2M
Q3 '18: -3.6M
Q4 '18: -4M
Q1 '19: -3.9M
Q2 '19: -3.6M
Q3 '19: -2.3M
Q4 '19: -2.8M
Q2 '21: -5.7M
Q3 '21: -6.3M
Q4 '21: -5.9M
Q1 '22: -7.1M
Q2 '22: -6.7M
Q3 '22: -4.4M
Q4 '22: -3.1M
Q1 '23: -2.8M
Q2 '23: -3.9M
Q3 '23: -5.8M
Q4 '23: -4.7M
Q1 '24: -2.7M
Q2 '24: -1.5M
Q3 '24: 760K
Q4 '24: 1.9M
Q1 '25: 586K
Q2 '25: 3.4M
Q3 '25: 2.6M
Q4 '25: 1.1M
Q1 '26: 1.3M
Q2 '26: -614K
Q2 '16
Q3 '17
Q4 '18
Q2 '21
Q3 '22
Q4 '23
Q1 '25
Q2 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
70M
140M
210M
Q1 '21: 119M
Q2 '21: 120.4M
Q3 '21: 125.7M
Q1 '22: 149.1M
Q2 '22: 149.2M
Q3 '22: 149.2M
Q1 '23: 149.7M
Q2 '23: 166.8M
Q3 '23: 171.3M
Q1 '24: 171.2M
Q2 '24: 171.1M
Q3 '24: 171.1M
Q1 '25: 176M
Q2 '25: 176M
Q3 '25: 175.9M
Q1 '26: 181M
Q2 '26: 184M
Q2 '21
Q2 '22
Q2 '23
Q2 '24
Q2 '25
Q2 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-0.75
-0.50
-0.25
0.00
0.25
0.50
0.75
Q3 '16: -0.08
Q4 '16: -0.07
Q1 '17: -0.07
Q2 '17: -0.07
Q3 '17: -0.06
Q4 '17: -0.07
Q1 '18: -0.07
Q2 '18: -0.07
Q3 '18: -0.08
Q4 '18: -0.11
Q1 '19: -0.10
Q2 '19: -0.09
Q3 '19: -0.10
Q4 '19: -0.06
Q1 '20: -0.08
Q2 '20: -0.11
Q3 '20: -0.64
Q4 '20: -0.63
Q1 '21: -0.62
Q2 '21: -0.62
Q3 '21: -0.08
Q4 '21: -0.10
Q1 '22: -0.09
Q2 '22: -0.06
Q3 '22: -0.05
Q4 '22: -0.12
Q1 '23: -0.14
Q2 '23: -0.17
Q3 '23: -0.28
Q4 '23: -0.23
Q1 '24: -0.23
Q2 '24: -0.22
Q3 '24: -0.12
Q4 '24: -0.10
Q1 '25: -0.09
Q2 '25: -0.08
Q3 '25: -0.08
Q4 '25: -0.08
Q1 '26: -0.07
Q2 '26: -0.07
Q3 '17
Q4 '18
Q1 '20
Q2 '21
Q3 '22
Q4 '23
Q1 '25
Q2 '26
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.